Source: Nuvision Blog

Nuvision Blog Published data shows Omnigen delivers a rapid and significant benefit in dry eye disease patients

Attendees at this week's prestigious Saudi Ophthalmology annual meeting - So2023 (link) from 19-21st October in Riyadh will learn about the latest clinical research outcomes on the sutureless, in-office application of Omnigen amniotic membrane as a new treatment for moderate-to-severe dry eye disease (DED). Managing DED symptoms is challenging. One in four of us will ... Read more

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Andy Hill's photo - CEO of NuVision

CEO

Andy Hill

CEO Approval Rating

90/100

Read more